How Is Cancer Managed at the End of Life?
Some oncologists are far more aggressive than others.
Research summaries with expert commentaries
RESEARCH SUMMARY | Nov 27, 2024
Some oncologists are far more aggressive than others.
RESEARCH SUMMARY | Nov 27, 2024
In a U.S. postmarketing surveillance study, only 1 in 6 IVC filters were retrieved.
RESEARCH SUMMARY | Nov 20, 2024
This randomized trial showed no difference in local or systemic side effects in patients receiving their vaccines on either schedule.
RESEARCH SUMMARY | Nov 13, 2024
The combinations of inhaled steroid/albuterol or inhaled steroid/formoterol clearly are superior to monotherapy for rescue.
RESEARCH SUMMARY | Nov 13, 2024
In this observational study, rosuvastatin was associated with lower 6-year mortality but interpreting and applying the results is not straightforward.
RESEARCH SUMMARY | Nov 6, 2024
The overall failure rate was 10% — central line–associated bloodstream infections, occlusions, and dislodgement were the main culprits.
RESEARCH SUMMARY | Nov 6, 2024
This potassium-competitive acid blocker recently was FDA approved for this indication, but its high cost is a barrier to routine use.
RESEARCH SUMMARY | Oct 30, 2024
A trio of trials provide more evidence for the safety and efficacy of SPCs to lower blood pressure.
RESEARCH SUMMARY | Oct 30, 2024
In a randomized trial, critically ill patients with acute brain injury who were transfused to a higher hemoglobin goal had better neurological outcomes.
RESEARCH SUMMARY | Oct 23, 2024
Commonly used nonstandard arm positions resulted in clinically relevant overestimation of BP.